Kurt H. Kruger, Director at Qualigen Therapeutics, Inc. (QLGN), bought 8,000 shares at $1.23 ($10K) on 2021-08-19, disclosed to the SEC on 2021-08-20.
Open-market purchase of $10k QLGN by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.22 | 4,000 | $5K | 49.8% |
| 2 | $1.23 | 4,000 | $5K | 50.2% |
| Total | $1.23 avg | 8,000 | $10K | 100% |
| Filing → |